COLORADO SPRINGS, Colo.,
March 26, 2015 /PRNewswire/ -- Choosing to present its
products to the world at this year's Spannabis Fair, held March
20-22 in Barcelona, Spain,
Cannabis Science, Inc. (OTCQB: CBIS) immediately began meeting with
representatives of businesses and organizations interested in
providing the products to their customers from across Spain.
"It was a huge success," stated, Mr. Mario S. Lap, European President of Operations.
"This is the initial exposure we want for the successful launch of
our brand in Europe letting the
world know about us and our product pipeline. We are very excited
to be in a position to simultaneously release our products in
several new consumer spaces enabling us to now take orders on a
wholesale level."
Over three days, Spannabis 2015 attracted an estimated 50,000
visitors from around the world - and it was a very busy event for
Cannabis Science. While Mr. Lap was taking initial product orders
and meeting with prospective customers, the company's multilingual
European operations team answered numerous questions about Cannabis
Science and its products from private individuals and companies and
organizations from across Europe,
Asia and the Americas.
"Interest in the company and our products was tremendous," said
Mr. Lap. "I have met with a significant number of new prospective
customers and a number of our targeted area representatives
responsible for purchases for their respective Companies, all of
whom are interested in our products in some form or another."
Under current Spanish regulatory structures, attendees
interested in the product consisted of three main types of
clientele:
- Cannabis companies that provide growing solutions, lighting and
seeds that are now emerging to play an important part in the
medical cannabis sector.
- Membership-only Spanish cannabis social clubs. In 2013, nearly
170,000 Spaniards started consuming cannabis. Cannabis Science sees
this as a large addressable market that can be educated about the
benefits of medical cannabinoid formulations and medicines.
- Organizations run by patients and doctors seeking to provide
quality cannabinoid-based medical products to patients across
Spain.
Spanish media coverage:
http://www.lamarihuana.com/spannabis-2015-reportaje-fotografico/
About Cannabis Science, Inc.
Cannabis Science, Inc.,
takes advantage of its unique understanding of metabolic processes
to provide novel treatment approaches to a number of illnesses for
which current treatments and understanding remain unsatisfactory.
Cannabinoids have an extensive history dating back thousands of
years, and currently, there are a growing number of peer-reviewed
scientific publications that document the underlying biochemical
pathways that cannabinoids modulate. The Company works with leading
experts in drug development, medicinal characterization, and
clinical research to develop, produce, and commercialize novel
therapeutic approaches for the treatment for illnesses caused by
infections as well as for age-related illness. Our initial focus is
on skin cancers, HIV/AIDS, and neurological conditions. The
Company is proceeding with the research and development of its
proprietary drugs as a part of this initial focus:
CS-S/BCC-1, CS-TATI-1, and CS-NEURO-1, respectively.
Forward-Looking Statements
This Press Release includes
forward-looking statements within the meaning of Section 27A of the
Securities Act of 1933 and Section 21E of the Securities Act of
1934. A statement containing words such as "anticipate," "seek,"
intend," "believe," "estimate," "expect," "project," "plan," or
similar phrases may be deemed "forward-looking statements" within
the meaning of the Private Securities Litigation Reform Act of
1995. Some or all of the events or results anticipated by these
forward-looking statements may not occur. Factors that could cause
or contribute to such differences include the future U.S. and
global economies, the impact of competition, and the Company's
reliance on existing regulations regarding the use and development
of cannabis-based drugs. Cannabis Science, Inc., does not undertake
any duty nor does it intend to update the results of these
forward-looking statements. Safe Harbor Statement. The
Private Securities Litigation Reform Act of 1995 provides a 'safe
harbor' for forward-looking statements. Certain of the
statements contained herein, which are not historical facts are
forward looking statements with respect to events, the occurrence
of which involved risks and uncertainties. These
forward-looking statements may be impacted, either positively or
negatively, by various factors. Information concerning
potential factors that could affect the company are detailed from
time to time in the company's reports filed with the Securities and
Exchange Commission.
Media Contacts:
VAN STONE PUBLICITY
Carrol Van
Stone
carrol@vanstonepublicity.com
Tel: 304-671-0244
Cannabis Science, Inc.
Raymond C.
Dabney
President & CEO, Co-Founder
info@cannabisscience.com
Tel: 1.888.889.0888
Chad S. Johnson, Esq.
Director, COO & General Counsel
info@cannabisscience.com
Tel: 1.888.889.0888
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/after-unveiling-its-products-at-premiere-global-cannabis-event-cannabis-science-inc-reports-strong-customer-interest-300056492.html
SOURCE Cannabis Science, Inc.